This inventor holds 1 USPTO granted patent. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Innovator of Nanoporous Membrane Technology: Jung-A Yang
Introduction: Jung-A Yang is a notable inventor based in Kyungsangbuk-do, South Korea, specializing in the development of advanced materials. With one patent to her name, she has made significant contributions to the field of biopharmaceutical delivery systems.
Latest Patents: Jung-A Yang's patent, titled "Nanoporous membrane, process of fabricating the same and device for controlled release of biopharmaceuticals comprising the same," introduces an innovative nanoporous membrane design. This membrane features a support structure with a first separation layer that possesses multiple nano-sized pores, along with a second separation layer that aligns with the first. The unique design allows for a density of pores equal to or exceeding 10/cm, ensuring that biopharmaceuticals can be released at a constant rate over extended periods, irrespective of their concentration. This advancement enables high flexibility and selectivity in drug delivery.
Career Highlights: Jung-A Yang's career is marked by her role at the Postech Academy-Industry Foundation, where she contributes her expertise to research and development endeavors. Her focus on enhancing drug delivery mechanisms demonstrates her commitment to merging scientific research with practical applications in healthcare.
Collaborations: In her work, Yang collaborates with fellow researchers Seung Yun Yang and Sei Kwang Hahn. These collaborations reflect a shared dedication to advancing biopharmaceutical technologies and underscores the importance of teamwork in achieving innovative breakthroughs.
Conclusion: Jung-A Yang stands out as a pioneering inventor in the realm of nanoporous membrane technology. Her contributions promise to revolutionize the way biopharmaceuticals are delivered, ensuring a more efficient and effective treatment for patients. With ongoing research and collaboration, her work will continue to impact the field positively.